DermDox

Hazleton, Pennsylvania 18201

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Rosacea

Studies at this site

• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
• Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed